Next, we examined the expression of Gli1 in ovarian cancer cell lines, and the in vitro effects of a specific hedghehog pathway blocker, KAAD-cyclopamine [9], [10] or a specific Gli1 inhibitor, GANT58 [11], on cell proliferation and on hedgehog target gene expression. This evidence concerns the gene GLI1 and ovarian cancer.